Matthias Alder - Dec 23, 2021 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Matthias Alder
Stock symbol
GANX
Transactions as of
Dec 23, 2021
Transactions value $
$1,172,000
Form type
4
Date filed
12/28/2021, 03:30 PM
Next filing
Jul 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Non Qualified Stock Option (right to buy) Award $1.17M +200K $5.86 200K Dec 23, 2021 Common Stock 200K $5.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 options shall vest on 10/15/2022 (the "Initial Vesting Date") and the remaining 150,000 options shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date.